Goldman Sachs Maintains Neutral on Oscar Health, Raises Price Target to $7.5
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Nathan Rich maintains a Neutral rating on Oscar Health (NYSE:OSCR) and raises the price target from $5.5 to $7.5.

August 10, 2023 | 1:33 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Goldman Sachs maintains a Neutral rating on Oscar Health and raises the price target from $5.5 to $7.5.
The news directly pertains to Oscar Health as Goldman Sachs maintains a Neutral rating on the company and raises the price target. This could indicate a potential increase in the stock's value, but the Neutral rating suggests that the stock's performance may remain stable in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100